A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism

被引:6
|
作者
Apaolaza, Inigo [1 ,2 ,3 ]
San Jose-Eneriz, Edurne [4 ,5 ,6 ]
Valcarcel, Luis V. [1 ,4 ,5 ]
Agirre, Xabier [4 ,5 ,6 ]
Prosper, Felipe [4 ,5 ,6 ,7 ]
Planes, Francisco J. [1 ,2 ,3 ]
机构
[1] Univ Navarra, Tecnun Escuela Ingn, San Sebastian, Spain
[2] Univ Navarra, Ctr Ingn Biomed, Pamplona, Spain
[3] Univ Navarra, DATAI Inst Ciencia Datos & Inteligencia Artificia, Pamplona, Spain
[4] Univ Navarra, CIMA Ctr Invest Med Aplicada, Pamplona, Spain
[5] IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain
[6] CIBERONC Ctr Invest Biomed Red Canc, Pamplona, Spain
[7] Clin Univ Navarra, Pamplona, Spain
关键词
CELLS; REQUIREMENTS;
D O I
10.1371/journal.pcbi.1009395
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies. Author summary Metabolic reprogramming is one of the hallmarks of tumor cells. Synthetic lethality (SL) is a promising approach to exploit these metabolic alterations and elucidate cancer-specific genetic dependences. However, current SL approaches do not systematically consider tumor microenvironment, which is particularly important in cancer metabolism in order to generalize identified genetic dependences. In this article, we directly address this issue and propose a more general approach to SL that integrates both genetic and environmental context of tumor cells. Our definition can help to contextualize genetic dependencies in different environmental scenarios, but it could also reveal nutrient dependencies according to the genetic context. We also provide a computational pipeline to identify this new family of synthetic lethals in genome-scale metabolic networks. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of cancer cell lines, elucidating cholesterol and myo-Inositol depletion as potential vulnerabilities in different malignancies.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] FERAL: network-based classifier with application to breast cancer outcome prediction
    Allahyar, Amin
    de Ridder, Jeroen
    BIOINFORMATICS, 2015, 31 (12) : 311 - 319
  • [42] Network-based approach to prediction and population-based validation of in silico drug repurposing
    Cheng, Feixiong
    Desai, Rishi J.
    Handy, Diane E.
    Wang, Ruisheng
    Schneeweiss, Sebastian
    Barabasi, Albert-Laszlo
    Loscalzo, Joseph
    NATURE COMMUNICATIONS, 2018, 9
  • [43] Network-based approach to prediction and population-based validation of in silico drug repurposing
    Feixiong Cheng
    Rishi J. Desai
    Diane E. Handy
    Ruisheng Wang
    Sebastian Schneeweiss
    Albert-László Barabási
    Joseph Loscalzo
    Nature Communications, 9
  • [44] The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
    Turinetto, Margherita
    Scotto, Giulia
    Tuninetti, Valentina
    Giannone, Gaia
    Valabrega, Giorgio
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] ELISL: early-late integrated synthetic lethality prediction in cancer
    Tepeli, Yasin, I
    Seale, Colm
    Goncalves, Joana P.
    BIOINFORMATICS, 2024, 40 (01)
  • [46] A Multilayer Perceptron Neural Network-Based Spectrum Prediction Approach with Gray Decision
    Ge, Jincheng
    Xu, Yuhua
    Liu, Dianxiong
    Kong, Lijun
    Chen, Xueqiang
    COMMUNICATIONS, SIGNAL PROCESSING, AND SYSTEMS, 2019, 463 : 2395 - 2404
  • [47] A Neural Network-based Approach for Public Transportation Prediction with Traffic Density Matrix
    Panovski, Dancho
    Scurtu, Veronica
    Zaharia, Titus
    PROCEEDINGS OF THE 2018 7TH EUROPEAN WORKSHOP ON VISUAL INFORMATION PROCESSING (EUVIP), 2018,
  • [48] MPASL: multi-perspective learning knowledge graph attention network for synthetic lethality prediction in human cancer
    Zhang, Ge
    Chen, Yitong
    Yan, Chaokun
    Wang, Jianlin
    Liang, Wenjuan
    Luo, Junwei
    Luo, Huimin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [49] A network-based approach for drug synergy prediction from gene expression data
    Alvarez, Mariano J.
    Shen, Yao
    Karan, Charles
    Bansal, Mukesh
    Mattioli, Michela
    Pampou, Sergey
    Califano, Andrea
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [50] Prediction of Metabolic Gene Biomarkers for Neurodegenerative Disease by an Integrated Network-Based Approach
    Ni, Qi
    Su, Xianming
    Chen, Jingqi
    Tian, Weidong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015